0001127602-24-016813.txt : 20240529
0001127602-24-016813.hdr.sgml : 20240529
20240529174226
ACCESSION NUMBER: 0001127602-24-016813
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240528
FILED AS OF DATE: 20240529
DATE AS OF CHANGE: 20240529
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Llorens Josep
CENTRAL INDEX KEY: 0001750812
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-14041
FILM NUMBER: 24999902
MAIL ADDRESS:
STREET 1: HAEMONETICS CORPORATION
STREET 2: 400 WOOD ROAD
CITY: BRAINTREE
STATE: MA
ZIP: 02184
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: HAEMONETICS CORP
CENTRAL INDEX KEY: 0000313143
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
ORGANIZATION NAME: 08 Industrial Applications and Services
IRS NUMBER: 042882273
STATE OF INCORPORATION: MA
FISCAL YEAR END: 0330
BUSINESS ADDRESS:
STREET 1: 125 SUMMER STREET
CITY: BOSTON
STATE: MA
ZIP: 02110
BUSINESS PHONE: 7818487100
MAIL ADDRESS:
STREET 1: 125 SUMMER STREET
CITY: BOSTON
STATE: MA
ZIP: 02110
4
1
form4.xml
PRIMARY DOCUMENT
X0508
4
2024-05-28
0000313143
HAEMONETICS CORP
HAE
0001750812
Llorens Josep
125 SUMMER STREET
BOSTON
MA
02110
1
EVP, Global Manufacturing
0
Common Stock
2024-05-28
4
A
0
14140
0
A
35450
D
Common Stock
2024-05-28
4
F
0
4510
95.73
D
30940
D
Represents shares earned from a performance share unit ("PSU") award granted to the reporting person on May 18, 2021, based on the issuer's total shareholder return relative to that of the companies comprising the S&P MidCap 400 Index for the performance period from May 18, 2021 to May 17, 2024, as certified by the Compensation Committee of the Board of Directors on May 26, 2024.
This number includes unvested restricted stock units ("RSUs") previously reported.
Represents shares withheld for tax obligations in connection with the vesting of certain PSUs reported in Table I.
/s/ Thomas V. Powers, attorney-in-fact for Mr. Llorens
2024-05-29